GEHC vs PSA · P/E 15, rev $20.63B vs rev $1.23B
GE HealthCare Technologies Inc. (GEHC) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
GE HealthCare Technologies Inc. (GEHC) is a medical devices company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported GEHC revenue for 2025-12-31 was $20.63B. Net income was $2.08B. Revenue was up 4.8% from 2024-12-31 to 2025-12-31. GEHC currently screens at market cap $27.82B and trailing P/E 14.7.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
GEHC currently screens at market cap $27.82B and trailing P/E 14.7. PSA currently screens at market cap $0.
Not investment advice. Open the GEHC and PSA stock pages for the full models.
Not investment advice.